Allin, M, Matsumoto, H, Santhouse, AM et al (2001) Cognitive and motor function and the size of the cerebellum in adolescents born very pre-term. Brain; 124: 60–6.
Arango, C, Bartko, JJ, Gold, JM et al (1999) Prediction of neuropsychological performance by neurological signs in schizophrenia. American Journal of Psychiatry; 156: 1349–57.
Arango, C, Kirkpatrick, B, Buchanan, RW (2000) Neurological signs and the heterogeneity of schizophrenia. American Journal of Psychiatry; 157: 560–5.
Bachmann, S, Bottmer, C, Schroder, J (2005) Neurological soft signs in first-episode schizophrenia: a follow-up study. American Journal of Psychiatry; 162: 2337–43.
Barkus, E, Stirling, J, Hopkins, R et al (2006) The presence of neurological soft signs along the psychosis proneness continuum. Schizophrenia Bulletin; 32: 573–7.
Barnes, TR (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry; 154: 672–6.
Boks, MP, Liddle, PF, Russo, S et al (2003) Influence of antipsychotic agents on neurological soft signs and dyskinesia in first episode psychosis. Psychiatry Research; 119: 167–70.
Boks, MP, Liddle, PF, Burgerhof, JG et al (2004) Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatrica Scandinavica; 110: 29–35.
Bombin, I, Arango, C, Buchanan, RW (2005) Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophrenia Bulletin; 31: 962–77.
Borgwardt, SJ, Radue, EW, Gotz, K et al (2006) Radiological findings in individuals at high risk of psychosis. Journal of Neurology, Neurosurgery, and Psychiatry; 77: 229–33.
Buchanan, RW, Heinrichs, DW (1989) The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research; 27: 335–50.
Caligiuri, MP, Lohr, JB (1997) Instrumental motor predictors of neuroleptic-induced Parkinsonism in newly medicated schizophrenia patients. Journal of Neuropsychiatry and Clinical Neurosciences; 9: 562–7.
Cannon, M, Walsh, E, Hollis, C et al (2001) Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department. British Journal of Psychiatry; 178: 420–6.
Cantor-Graae, E, McNeil, TF, Rickler, KC et al (1994) Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma?
American Journal of Psychiatry; 151: 1194–9.
Cantor-Graae, E, Ismail, B, McNeil, TF (2000) Are neurological abnormalities in schizophrenic patients and their siblings the result of perinatal trauma?
Acta Psychiatrica Scandinavica; 101: 142–7.
Carnahan, RM, Lund, BC, Perry, PJ et al (2006) Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatrica Scandinavica; 113: 135–41.
Casey, DE (2006) Implications of the CATIE trial on treatment: extrapyramidal symptoms. CNS Spectrums; 11: 25–31.
Chen, EY, Shapleske, J, Luque, R et al (1995) The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Research; 56: 183–204.
Convit, A, Volavka, J, Czobor, P et al (1994) Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. American Journal of Psychiatry; 151: 49–56.
Crow, TJ, Done, DJ, Sacker, A (1995) Childhood precursors of psychosis as clues to its evolutionary origins. European Archives of Psychiatry and Clinical Neuroscience; 245: 61–9.
Dazzan, P, Murray, RM (2002) Neurological soft signs in first-episode psychosis: a systematic review. British Journal of Psychiatry; 181 (suppl 43): s50–7.
Dazzan, P, Morgan, KD, Orr, KG et al (2004) The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain; 127: 143–53.
Dazzan, P, Morgan, KD, Orr, KG et al (2005) Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology; 30: 765–74.
Dazzan, P, Lloyd, T, Morgan, KD et al (2008) Neurological abnormalities and cognitive ability in first-episode psychosis. British Journal of Psychiatry; 193: 197–202.
Egan, MF, Hyde, TM, Bonomo, JB et al (2001) Relative risk of neurological signs in siblings of patients with schizophrenia. American Journal of Psychiatry; 158: 1827–34.
Emsley, RA, Turner, HJ, Oosthuizen, PP et al (2005) Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophrenia Research; 75: 35–44.
Erhart, SM, Young, AS, Marder, SR et al (2005) Clinical utility of magnetic resonance imaging radiographs for suspected organic syndromes in adult psychiatry. Journal of Clinical Psychiatry; 66: 968–73.
Galderisi, S, Maj, M, Mucci, A et al (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. American Journal of Psychiatry; 159: 983–90.
Gangadhar, BN, Jayakumar, PN, Venkatasubramanian, G et al (2006) Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry; 30: 910–3.
Gourion, D, Goldberger, C, Olie, JP et al (2004) Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophrenia Research; 67: 23–31.
Heinrichs, DW, Buchanan, RW (1988) Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry; 145: 11–8.
Ho, BC, Mola, C, Andreasen, NC (2004) Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biological Psychiatry; 55: 1146–53.
Hollister, LE, Shah, NN (1996) Structural brain scanning in psychiatric patients: a further look. Journal of Clinical Psychiatry; 57: 241–4.
Ismail, BT, Cantor-Graae, E, Cardenal, S et al (1998) Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophrenia Research; 30: 229–38.
Ismail, B, Cantor-Graae, E, McNeil, TF (2001) Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings. Schizophrenia Bulletin; 27: 629–41.
Keshavan, MS, Sanders, RD, Sweeney, JA et al (2003) Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. American Journal of Psychiatry; 160: 1298–304.
Kraepelin, E (1919) Dementia Praecox and Paraphrenia. Livingston.
Lawrie, SM, Byrne, M, Miller, P et al (2001) Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. British Journal of Psychiatry; 178: 524–30.
Lencer, R, Eismann, G, Kasten, M et al (2004) Family history of primary movement disorders as a predictor for neuroleptic-induced extrapyramidal symptoms. British Journal of Psychiatry; 185: 465–71.
Liddle, PF (1987) The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. British Journal of Psychiatry; 151: 145–51.
Lieberman, JA, Stroup, TS, McEvoy, JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine; 353: 1209–23.
McCreadie, RG, Thara, R, Padmavati, R et al (2002) Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Archives of General Psychiatry; 59: 332–6.
McCreadie, RG, Srinivasan, TN, Padmavati, R et al (2005) Extrapyramidal symptoms in unmedicated schizophrenia. Journal of Psychiatry Research; 39: 261–6.
McNeil, TF, Cantor-Graae, E (2000) Neuromotor markers of risk for schizophrenia. Australian and New Zealand Journal of Psychiatry; 34 (suppl): s86–90.
Miller, DD, McEvoy, JP, Davis, SM et al (2005) Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophrenia Research; 80: 33–43.
Mohr, F, Hubmann, W, Albus, M et al (2003) Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Research; 121: 21–30.
Mueller, C, Rufer, M, Moergeli, H et al (2006) Brain imaging in psychiatry – a study of 435 psychiatric in-patients at a university clinic. Acta Psychiatrica Scandinavica; 114: 91–100.
Nasrallah, HA, Tippin, J, McCalley-Whitters, M (1983) Neurological soft signs in manic patients. A comparison with schizophrenic and control groups. Journal of Affective Disorders; 5: 45–50.
National Institute of Mental Health (1976) Abnormal Involuntary Movement Scale (AIMS). In ECDEU: Assessment Manual for Psychopharmacology (ed Guy, W) pp 534–7. US Department of Health, Education, and Welfare.
Picchioni, MM, Toulopoulou, T, Landau, S et al (2006) Neurological abnormalities in schizophrenic twins. Biological Psychiatry; 59: 341–8.
Potvin, S, Pampoulova, T, Mancini-Marie, A et al (2006) Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. Journal of Neurology, Neurosurgery, and Psychiatry; 77: 796–8.
Prikryl, R, Ceskova, E, Kasparek, T et al (2006) Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. Journal of Psychiatry Research; 40: 141–6.
Rao, H, Di, X, Chan, RC et al (2008) A regulation role of the prefrontal cortex in the fist-edge-palm task: evidence from functional connectivity analysis. Neuroimage; 41: 1345–51.
Rossi, A, De Cataldo, S, Di Michele, V et al (1990) Neurological soft signs in schizophrenia. British Journal of Psychiatry; 157: 735–9.
Rubin, P, Vorstrup, S, Hemmingsen, R et al (1994) Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatrica Scandinavica; 90: 385–90.
Sachdev, P, Brodaty, H, Rose, N et al (1999) Schizophrenia with onset after age 50 years. 2: Neurological, neuropsychological and MRI investigation. British Journal of Psychiatry; 175: 416–21.
Sanders, RD, Schuepbach, D, Goldstein, G et al (2004) Relationships between cognitive and neurological performance in neuroleptic-naive psychosis. Journal of Neuropsychiatry and Clinical Neurosciences; 16: 480–7.
Scheffer, RE (2004) Abnormal neurological signs at the onset of psychosis. Schizophrenia Research; 70: 19–26.
Schroder, J, Niethammer, R, Geider, FJ et al (1991) Neurological soft signs in schizophrenia. Schizophrenia Research; 6: 25–30.
Schroder, J, Wenz, F, Schad, LR et al (1995) Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. British Journal of Psychiatry; 167: 197–201.
Schubert, EW, McNeil, TF (2004) Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. American Journal of Psychiatry; 161: 1030–7.
Schubert, EW, McNeil, TF (2005) Neuropsychological impairment and its neurological correlates in adult offspring with heightened risk for schizophrenia and affective psychosis. American Journal of Psychiatry; 162: 758–66.
Simpson, GM, Angus, JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica; 212 (suppl): 11–19.
Smith, RC, Kadewari, RP, Rosenberger, JR et al (1999) Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests. Schizophrenia Bulletin; 25: 813–25.
Srinivasan, TN, Thara, R, Padmavathi, R et al (2001) Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients. Schizophrenia Research; 47: 69–75.
Tarbox, SI, Pogue-Geile, MF (2006) Spontaneous dyskinesia and familial liability to schizophrenia. Schizophrenia Research; 81: 125–37.
Tarsy, D, Baldessarini, RJ (2006) Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
Movement Disorders; 21: 589–98.
Tosato, S, Dazzan, P (2005) The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Current Opinion in Psychiatry; 18: 285–8.
Venkatasubramanian, G, Latha, V, Gangadhar, BN et al (2003) Neurological soft signs in never-treated schizophrenia. Acta Psychiatrica Scandinavica; 108: 144–6.
Walterfang, M, Velakoulis, D (2005) Cortical release signs in psychiatry. Australian and New Zealand Journal of Psychiatry; 39: 317–27.
Weinberger, DR, Wyatt, RJ (1982) Cerebral ventricular size: a biological marker for sub-typing chronic schizophrenia. In Biological Markers in Psychiatry and Neurology (ed Usdin, EE) pp 505–12. Pergamon Press.
Whitty, P, Clarke, M, Browne, S et al (2003) Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine; 33: 1479–84.
Whitty, P, Clarke, M, McTigue, O et al (2006) Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophrenia Research; 86: 110–7.
Wojcik, JD, Gelenberg, AJ, LaBrie, RA et al (1980) Prevalence of tardive dyskinesia in an outpatient population. Comprehensive Psychiatry; 21: 370–80.
Wonodi, I, Adami, HM, Cassady, SL et al (2004) Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center. Journal of Clinical Psychopharmacology; 24: 592–8.
Yazici, AH, Demir, B, Yazici, KM et al (2002) Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophrenia Research; 58: 241–6.